Viewing Study NCT04842604


Ignite Creation Date: 2025-12-24 @ 7:56 PM
Ignite Modification Date: 2026-01-29 @ 12:34 PM
Study NCT ID: NCT04842604
Status: COMPLETED
Last Update Posted: 2023-12-18
First Post: 2021-04-08
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Continuation Study of B1371019(NCT03416179) and B1371012(NCT02367456) Evaluating Azacitidine With Or Without Glasdegib In Patients With Previously Untreated AML, MDS or CMML
Sponsor: Pfizer
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Acute Myeloid Leukemia View
None Myelodysplastic Syndrome View
None Chronic Myelomonocytic Leukemia View
Keywords: